These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 701764)

  • 1. Pharmacological alterations in the clotting mechanism: use in microvascular surgery.
    Ketchum LD
    J Hand Surg Am; 1978 Sep; 3(5):407-15. PubMed ID: 701764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy (first of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of "anti-platelet" drugs on bleeding time and platelet aggregation in normal human subjects.
    Buchanan GR; Martin V; Levine PH; Scoon K; Handin RI
    Am J Clin Pathol; 1977 Sep; 68(3):355-9. PubMed ID: 331937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetics of I-131 fibrinogen in cancer patients: pharmacological approach].
    Boneu-Valmalette A; Bugat R; David JF; Combes PF
    C R Seances Soc Biol Fil; 1977; 171(6):1293-6. PubMed ID: 148961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of heparin and ASA on changes of haemostasis induced by venous occlusion (author's transl)].
    Vinazzer H; Loew D
    Blut; 1978 May; 36(5):275-83. PubMed ID: 656635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of thrombotic diseases.
    Douglas AS
    Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemostasis suppression by a combination of heparin and acetylsalicylic acid].
    Wamhoff D; Schmechel H
    Z Gesamte Inn Med; 1975 Sep; 30(18):178-80. PubMed ID: 1216936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextran and haemostasis. A review.
    Bergqvist D
    Acta Chir Scand; 1982; 148(8):633-40. PubMed ID: 6189321
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the bleeding mechanism during fibrinolysis induced by streptokinase in the rabbit (author's transl)].
    Bara L; Samama M; Bilski-Pasquier G; Bloch MF; Rochas S
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():48-54. PubMed ID: 353658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a blood extract on plasma lipids, blood coagulation, fibrinolysis and platelet aggregation in experimental hypercholesterolemia of rabbits].
    Giarola P; Egge H; Gibelli A; Murawski U
    Arzneimittelforschung; 1974 Jun; 24(6):925-8. PubMed ID: 4408049
    [No Abstract]   [Full Text] [Related]  

  • 12. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum lipids following experimental fibrinolysis].
    Suschke J; Kunze D; von Pilar CE; Krejci K
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):388-9. PubMed ID: 4270871
    [No Abstract]   [Full Text] [Related]  

  • 14. Some effects of a microcrystalline collagen preparation on blood.
    Mason RG; Read MS
    Haemostasis; 1974; 3(1):31-45. PubMed ID: 4215704
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clotting and fibrinolysis.
    Prentice CR
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():50-3. PubMed ID: 182726
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet function and pharmacologic inhibition.
    Chaer RA; Graham JA; Mureebe L
    Vasc Endovascular Surg; 2006; 40(4):261-7. PubMed ID: 16959718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and contact activation of blood clotting. Influence of some aggregation inhibitors.
    Coccheri S; Alessandri M; De Rosa V
    Acta Med Scand Suppl; 1971; 525():253-6. PubMed ID: 5292097
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood and neoplastic diseases. Haemostasis, haemorrhage, and thrombosis.
    Ogston D; Douglas AS
    Br Med J; 1974 Sep; 3(5934):787-9. PubMed ID: 4278013
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.